Holen Sie sich die Stockscreener-App
0.7001
3.85%
-0.028
Handel nachbörslich:
.70
-0.000100
-0.01%
Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten
GSA Capital Partners LLP Makes New $1.97 Million Investment in Tenaya Therapeutics, Inc. $TNYA - MarketBeat
Tenaya Therapeutics (TNYA) Q2 2026 Earnings: EPS Misses by 186.94% as Clinical-Stage Pipeline Drives Wider-Than-Expected LossEarnings Power Value - dars.gov.et
symbol__ Stock Quote Price and Forecast - CNN
Transcript : Tenaya Therapeutics, Inc. Presents at Canaccord Genuity's 46th Annual Growth Conference, Aug-11-2026 12 - marketscreener.com
Tenaya Therapeutics (TNYA) Institutional Ownership 2026 - MarketBeat
Tenaya Therapeutics at Canaccord Genuity conference: q4 catalysts loom By Investing.com - Investing.com Canada
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Renaissance Technologies LLC Increases Stock Holdings in Tenaya Therapeutics, Inc. $TNYA - MarketBeat
HC Wainwright Has Positive Outlook of TNYA FY2026 Earnings - MarketBeat
Q3 Earnings Forecast for TNYA Issued By HC Wainwright - MarketBeat
H.C. Wainwright Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $3 - Moomoo
William Blair Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating - Moomoo
Tenaya Therapeutics (NASDAQ:TNYA) Issues Quarterly Earnings Results - MarketBeat
Tenaya Therapeutics (TNYA) Gains 5.81% as Biotech Stock Holds Above Critical $0.74 SupportZero Gamma Level - dars.gov.et
Tenaya Therapeutics, Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Tenaya Therapeutics Q2 net loss widens on impairment charge - TradingView
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Tenaya Therapeutics (TNYA) Jumps 5.8% to $0.78 as It Tests Key Resistance at $0.82Watchlist Stock Ideas - dars.gov.et
Tenaya Therapeutics (TNYA) to Post Earnings on Wednesday - MarketBeat
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Tenaya CFO Eric Hyllengren to Speak at Boston Conference - Stock Titan
Tenaya Therapeutics (TNYA) Slips to $0.74 as Key Support at $0.70 Comes into FocusButterfly Setup - dars.gov.et
Tenaya Therapeutics Inc (TNYA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TNYA|Tenaya Therapeutics Inc|Price:0.769|Chg%:-0.006 - TradingKey
Tenaya Therapeutics Inc (TNYA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tenaya Therapeutics Inc (TNYA) Cash Flow - TradingKey
Tenaya Therapeutics, Inc. Revenue Breakdown – NASDAQ:TNYA - TradingView
Tenaya Therapeutics Inc (TNYA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tenaya Therapeutics Inc (TNYA) Institutional Confidence - TradingKey
Tenaya Therapeutics Q1 2026 Earnings: Slight EPS Miss as Pre-Revenue Biotech Advances Heart Disease Pipeline - dars.gov.et
Tenaya Therapeutics Inc. (TNYA) Q1 2026 Earnings: EPS Slightly Misses Estimates, Stock Declines as Pre-Revenue Biotech Continues Pipeline DevelopmentReturn On Equity - dars.gov.et
Tenaya’s new CFO gets options on 1.65M shares, with a $0.8365 exercise price - Stock Titan
Tenaya Therapeutics (TNYA) CFO files first Form 3 ownership report - Stock Titan
Tenaya Therapeutics (TNYA) grants CFO 1,650,000 stock options - Stock Titan
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Tenaya Therapeutics Inc. (TNYA) Q1 2026 Earnings: Slight EPS Miss Overshadowed by Pipeline ProgressFinancial Summary - dars.gov.et
Tenaya Therapeutics, Inc. Podcast | TNYA Podcasts & Related Content - finance.biggo.com
TNYA News | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Tenaya Therapeutics (TNYA) - The Globe and Mail
Piper Sandler reiterates Overweight on Tenaya stock, $40 target - Investing.com
TNYATenaya Therapeutics Inc Options - Finviz
Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) Path To Profitability - simplywall.st
Tenaya Therapeutics Ends Manufacturing Center Lease, Shifts Strategy - The Globe and Mail
Tenaya Therapeutics (NASDAQ: TNYA) exits Union City manufacturing lease, shifts to CDMO - Stock Titan
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer - Investing News Network
Tenaya Therapeutics appoints Eric Hyllengren as CFO By Investing.com - Investing.com Australia
Tenaya Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective July 13, 2026 - marketscreener.com
Tenaya Therapeutics Appoints New Chief Financial Officer - TipRanks
Eric Hyllengren to lead finances at Tenaya Therapeutics (NASDAQ: TNYA) - Stock Titan
Tenaya Therapeutics appoints Eric Hyllengren as CFO - Investing.com
Press Release: Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer - Moomoo
Price to book forward of Tenaya Therapeutics, Inc. – NASDAQ:TNYA - TradingView
Price to sales forward of Tenaya Therapeutics, Inc. – NASDAQ:TNYA - TradingView
Price to earnings forward of Tenaya Therapeutics, Inc. – NASDAQ:TNYA - TradingView
Enterprise value to revenue forward of Tenaya Therapeutics, Inc. – NASDAQ:TNYA - TradingView
TENAYA THERAPEUTICS INC (TNYA) Stock Chart - ChartMill
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):